A Phase I Trial of Capecitabine Rapidly Disintegrating Tablets and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas and High Grade Gliomas

Trial Profile

A Phase I Trial of Capecitabine Rapidly Disintegrating Tablets and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas and High Grade Gliomas

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Dec 2016

At a glance

  • Drugs Capecitabine (Primary)
  • Indications Glioma
  • Focus Adverse reactions
  • Sponsors Roche
  • Most Recent Events

    • 16 Mar 2012 Actual number of patients changed from 8 to 24 as reported by ClinicalTrials.gov.
    • 28 Apr 2011 Planned End Date changed from 1 Apr 2010 to 1 Sep 2013 according to ClinicalTrials.gov record.
    • 17 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top